Clinical Trial Detail

NCT ID NCT01371630
Title Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphocytic leukemia

Therapies

inotuzumab ozogamicin

Cyclophosphamide + Cytarabine + inotuzumab ozogamicin + Methotrexate + Vincristine

Mercaptopurine + Methotrexate + Prednisone + Vincristine

Rituximab

Cytarabine + inotuzumab ozogamicin + Methotrexate

Age Groups: senior adult

Additional content available in CKB BOOST